Skip to main content
Log in

Plattenepithelkarzinome des Kopf-Hals-Bereichs

Risikofaktor HPV

  • Fortbildung
  • Published:
HNO Nachrichten Aims and scope

Bis vor einigen Jahren galten nur Alkohol und Rauchen als gesicherter Risikofaktor für Kopf-Hals-Tumoren. Mittlerweile hat sich gezeigt: Für die Entwicklung von Plattenepithelkarzinomen des Kopf-Hals-Bereichs spielen auch Infektionen mit humanen Papillomaviren (HPV) eine immer bedeutendere Rolle.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2

Literatur

  1. Boyle P, Ferlay J. Cancer incidence and mortality in Europe, 2004. Ann Oncol 2005;16:481–8.

    Article  CAS  PubMed  Google Scholar 

  2. Wittekindt C, Wagner S, Mayer CS, Klussmann JP. Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg 2012;11:Doc09.

    PubMed  PubMed Central  Google Scholar 

  3. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359–86.

    Article  CAS  PubMed  Google Scholar 

  4. Wittekind C, Weber, A. & Weidenbach, H. Pathologie und Prognosefaktoren von Plattenepithelkarzinomen des Kopf-Hals-Bereiches. Onkologe 2001:498–504.

    Google Scholar 

  5. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001;92:2875–84.

    Article  CAS  PubMed  Google Scholar 

  6. Bucchi D, Stracci F, Buonora N, Masanotti G. Human papillomavirus and gastrointestinal cancer: A review. World J Gastroenterol 2016;22:7415–30.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Huebbers CU, Preuss SF, Kolligs J, et al. Integration of HPV6 and downregulation of AKR1C3 expression mark malignant transformation in a patient with juvenile-onset laryngeal papillomatosis. PLoS One 2013;8:e57207.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Reuschenbach M, Wagner S, Wurdemann N, et al. [Human papillomavirus and squamous cell cancer of the head and neck region: Prognostic, therapeutic and prophylactic implications]. HNO 2016;64:450–9.

    Article  CAS  PubMed  Google Scholar 

  9. Keck MK, Zuo Z, Khattri A, et al. Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes. Clin Cancer Res 2015;21:870–81.

    Article  CAS  PubMed  Google Scholar 

  10. Wagner S, Wurdemann N, Hubbers C, et al. [HPV-associated head and neck cancer: mutational signature and genomic aberrations]. HNO 2015;63:758–67.

    Article  CAS  PubMed  Google Scholar 

  11. Prigge ES, Toth C, Dyckhoff G, et al. p16(INK4a) /Ki-67 co-expression specifically identifies transformed cells in the head and neck region. Int J Cancer 2015;136:1589–99.

    Article  CAS  PubMed  Google Scholar 

  12. Klussmann JP, Gultekin E, Weissenborn SJ, et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 2003;162:747–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Rosenquist K. Risk factors in oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Swed Dent J Suppl 2005:1–66.

    Google Scholar 

  14. Palmer E, Newcombe RG, Green AC, et al. Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions. Int J Cancer 2014;135:2437–43.

    Article  CAS  PubMed  Google Scholar 

  15. Meyer MF, Huebbers CU, Siefer OG, et al. Prevalence and risk factors for oral human papillomavirus infection in 129 women screened for cervical HPV infection. Oral Oncol 2014;50:27–31.

    Article  PubMed  Google Scholar 

  16. Kreimer AR, Bhatia RK, Messeguer AL, Gonzalez P, Herrero R, Giuliano AR. Oral human papillomavirus in healthy individuals: a systematic review of the literature. Sex Transm Dis 2010;37:386–91.

    PubMed  Google Scholar 

  17. Shah SS, Senapati S, Klacsmann F, et al. Current Technologies and Recent Developments for Screening of HPV-Associated Cervical and Oropharyngeal Cancers. Cancers (Basel) 2016;8.

    Google Scholar 

  18. Chancellor JA, Ioannides SJ, Elwood JM. Oral and oropharyngeal cancer and the role of sexual behaviour: a systematic review. Community Dent Oral Epidemiol 2016.

    Google Scholar 

  19. Ndiaye C, Mena M, Alemany L, et al. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 2014;15:1319–31.

    Article  CAS  PubMed  Google Scholar 

  20. Castellsague X, Mena M, Alemany L. Epidemiology of HPV-Positive Tumors in Europe and in the World. Recent Results Cancer Res 2017;206:27–35.

    Article  PubMed  Google Scholar 

  21. Nasman A, Attner P, Hammarstedt L, et al. Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 2009;125:362–6.

    Article  PubMed  Google Scholar 

  22. Tinhofer I, Johrens K, Keilholz U, et al. Contribution of human papilloma virus to the incidence of squamous cell carcinoma of the head and neck in a European population with high smoking prevalence. Eur J Cancer 2015;51:514–21.

    Article  CAS  PubMed  Google Scholar 

  23. Hoffmann M, Tribius S, Quabius ES, et al. HPV DNA, E6*I-mRNA expression and p16INK4A immunohistochemistry in head and neck cancer - how valid is p16INK4A as surrogate marker? Cancer Lett 2012;323:88–96.

    Article  CAS  PubMed  Google Scholar 

  24. Ziemann F, Arenz A, Preising S, et al. Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation +/- Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis. Am J Cancer Res 2015;5:1017–31.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Arenz A, Ziemann F, Mayer C, et al. Increased radiosensitivity of HPV-positive head and neck cancer cell lines due to cell cycle dysregulation and induction of apoptosis. Strahlenther Onkol 2014;190:839–46.

    Article  PubMed  Google Scholar 

  26. Zevallos JP, Mazul AL, Rodriguez N, et al. Previous tonsillectomy modifies odds of tonsil and base of tongue cancer. Br J Cancer 2016;114:832–8.

    Article  PubMed  Google Scholar 

  27. Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012;12:252–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Massarelli E, Ferrarotto R, Glisson BS. New Strategies in Human Papillomavirus-Related Oropharynx Cancer: Effecting Advances in Treatment for a Growing Epidemic. Clin Cancer Res 2015;21:3821–8.

    Article  CAS  PubMed  Google Scholar 

  29. Ferris RL, Blumenschein G, Jr., Fayette J, et al. Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck. N Engl J Med 2016.

    Google Scholar 

  30. Wagner S, Wittekindt C, Reuschenbach M, et al. CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma. Int J Cancer 2016;138:2263–73.

    Article  CAS  PubMed  Google Scholar 

  31. Armstrong LR, Derkay CS, Reeves WC. Initial results from the national registry for juvenile-onset recurrent respiratory papillomatosis. RRP Task Force. Arch Otolaryngol Head Neck Surg 1999;125:743–8.

    Article  CAS  PubMed  Google Scholar 

  32. Lindeberg H, Elbrond O. Laryngeal papillomas: the epidemiology in a Danish subpopulation 1965-1984. Clin Otolaryngol Allied Sci 1990;15:125–31.

    Article  CAS  PubMed  Google Scholar 

  33. Carifi M, Napolitano D, Morandi M, Dall’Olio D. Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag 2015;11:731–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Hartwig S, Syrjanen S, Dominiak-Felden G, Brotons M, Castellsague X. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 2012;12:30.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Gillison ML, Chaturvedi AK, Anderson WF, Fakhry C. Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma. J Clin Oncol 2015;33:3235–42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Tobias Kroll.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kroll, T., Sharma, S.J., Ahrens, K. et al. Risikofaktor HPV. HNO Nachrichten 47, 35–38 (2017). https://doi.org/10.1007/s00060-017-5389-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00060-017-5389-7

Navigation